Evidence map›Paper›PMID 40506238›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Evaluation of

Kondapa Naidu Bobba, Anju Wadhwa, Anil P Bidkar, Athira Raveendran, Luis Garcia, Nancy Greenland, David M Wilson, Youngho Seo, Henry F VanBrocklin, Robert R Flavell

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kondapa Naidu BobbaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Anju WadhwaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Anil P BidkarDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Athira RaveendranDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Luis GarciaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Nancy GreenlandDepartment of Pathology, University of California, San Francisco, California.
David M WilsonDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Youngho SeoDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Henry F VanBrocklinDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Robert R FlavellDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California; robert.flavell@ucsf.edu.

Funding

Systematic evaluation of toxicity and therapeutic efficacy in CD46 directed radioligand therapyR01CA279203 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Robert Richard Flavell, Youngho Seo · 2023 to 2026
$2.6M
NCI NIH HHS R01 CA279203
6 · The paper itself

Abstract

The

Indexed as

DipeptidesElectronsHeterocyclic Compounds, 1-RingPositron-Emission TomographyProstatic NeoplasmsAnimalsCell Line, TumorHumansMaleMiceProstate-Specific AntigenRadiopharmaceuticalsTissue DistributionDipeptidesHeterocyclic Compounds, 1-RingProstate-Specific AntigenPSMA-617Radiopharmaceuticals[134Ce]Ce-PSMA-617Auger electronsprostate cancertargeted radiopharmaceutical therapy

Identifiers

PMID40506238
PMCPMC12320565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.